Literature DB >> 25584016

GENETIC CAUSES OF DILATED CARDIOMYOPATHY.

Luisa Mestroni1, Francesca Brun2, Anita Spezzacatene2, Gianfranco Sinagra3, Matthew Rg Taylor1.   

Abstract

Dilated cardiomyopathy is a disease of the myocardium characterized by left ventricular dilatation and/or dysfunction, affecting both adult and pediatric populations. Almost half of cases are genetically determined with an autosomal pattern of inheritance. Up to 40 genes have been identified affecting proteins of a wide variety of cellular structures such as the sarcomere, the nuclear envelope, the cytoskeleton, the sarcolemma and the intercellular junction. Novel gene mutations have been recently identified thanks to advances in next-generation sequencing technologies. Genetic screening is an essential tool for early diagnosis, risk assessment, prognostic stratification and, possibly, adoption of primary preventive measures in affected patients and their asymptomatic relatives. The purpose of this article is to review the genetic basis of DCM, the known genotype-phenotype correlations, the role of current genetic sequencing techniques in the discovery of novel pathogenic gene mutations and new therapeutic perspectives.

Entities:  

Keywords:  Dilated cardiomyopathy; gene; heart failure; pediatrics; prognosis; screening

Year:  2014        PMID: 25584016      PMCID: PMC4288017          DOI: 10.1016/j.ppedcard.2014.10.003

Source DB:  PubMed          Journal:  Prog Pediatr Cardiol        ISSN: 1058-9813


  80 in total

1.  2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation.

Authors:  Mariell Jessup; William T Abraham; Donald E Casey; Arthur M Feldman; Gary S Francis; Theodore G Ganiats; Marvin A Konstam; Donna M Mancini; Peter S Rahko; Marc A Silver; Lynne Warner Stevenson; Clyde W Yancy
Journal:  Circulation       Date:  2009-03-26       Impact factor: 29.690

2.  Epidemiology of dilated cardiomyopathy. A prospective post-mortem study of 5252 necropsies. The Heart Muscle Disease Study Group.

Authors:  S Rakar; G Sinagra; A Di Lenarda; A Poletti; R Bussani; F Silvestri; F Camerini
Journal:  Eur Heart J       Date:  1997-01       Impact factor: 29.983

3.  Poor prognosis of rare sarcomeric gene variants in patients with dilated cardiomyopathy.

Authors:  Marco Merlo; Gianfranco Sinagra; Elisa Carniel; Dobromir Slavov; Xiao Zhu; Giulia Barbati; Anita Spezzacatene; Federica Ramani; Ernesto Salcedo; Andrea Di Lenarda; Luisa Mestroni; Matthew R G Taylor
Journal:  Clin Transl Sci       Date:  2013-10-03       Impact factor: 4.689

4.  Incidence, causes, and outcomes of dilated cardiomyopathy in children.

Authors:  Jeffrey A Towbin; April M Lowe; Steven D Colan; Lynn A Sleeper; E John Orav; Sarah Clunie; Jane Messere; Gerald F Cox; Paul R Lurie; Daphne Hsu; Charles Canter; James D Wilkinson; Steven E Lipshultz
Journal:  JAMA       Date:  2006-10-18       Impact factor: 56.272

5.  Natural history of dilated cardiomyopathy due to lamin A/C gene mutations.

Authors:  Matthew R G Taylor; Pamela R Fain; Gianfranco Sinagra; Misi L Robinson; Alastair D Robertson; Elisa Carniel; Andrea Di Lenarda; Teresa J Bohlmeyer; Debra A Ferguson; Gary L Brodsky; Mark M Boucek; Jean Lascor; Andrew C Moss; Wai Lun P Li; Gary L Stetler; Francesco Muntoni; Michael R Bristow; Luisa Mestroni
Journal:  J Am Coll Cardiol       Date:  2003-03-05       Impact factor: 24.094

Review 6.  Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy.

Authors:  L Mestroni; B Maisch; W J McKenna; K Schwartz; P Charron; C Rocco; F Tesson; A Richter; A Wilke; M Komajda
Journal:  Eur Heart J       Date:  1999-01       Impact factor: 29.983

7.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.

Authors:  Barry J Maron; Jeffrey A Towbin; Gaetano Thiene; Charles Antzelevitch; Domenico Corrado; Donna Arnett; Arthur J Moss; Christine E Seidman; James B Young
Journal:  Circulation       Date:  2006-03-27       Impact factor: 29.690

8.  Clinical trials update: OPTIME-CHF, PRAISE-2, ALL-HAT.

Authors:  S Thackray; K Witte; A L Clark; J G Cleland
Journal:  Eur J Heart Fail       Date:  2000-06       Impact factor: 15.534

9.  Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984.

Authors:  M B Codd; D D Sugrue; B J Gersh; L J Melton
Journal:  Circulation       Date:  1989-09       Impact factor: 29.690

10.  Subtle abnormalities in contractile function are an early manifestation of sarcomere mutations in dilated cardiomyopathy.

Authors:  Neal K Lakdawala; Jens J Thune; Steven D Colan; Allison L Cirino; Faranak Farrohi; Jose Rivero; Barbara McDonough; Elizabeth Sparks; E J Orav; J G Seidman; Christine E Seidman; Carolyn Y Ho
Journal:  Circ Cardiovasc Genet       Date:  2012-09-04
View more
  37 in total

1.  Genetic Testing in Pediatric Cardiomyopathy.

Authors:  Chalani D Ellepola; Linda M Knight; Peter Fischbach; Shriprasad R Deshpande
Journal:  Pediatr Cardiol       Date:  2017-11-29       Impact factor: 1.655

Review 2.  Genetic Variation in Cardiomyopathy and Cardiovascular Disorders.

Authors:  Elizabeth M McNally; Megan J Puckelwartz
Journal:  Circ J       Date:  2015-06-04       Impact factor: 2.993

Review 3.  Precision medicine approach to genetic cardiomyopathy.

Authors:  K Filonenko; H A Katus; B Meder
Journal:  Herz       Date:  2017-08       Impact factor: 1.443

Review 4.  Lamin A/C Cardiomyopathy: Implications for Treatment.

Authors:  Suet Nee Chen; Orfeo Sbaizero; Matthew R G Taylor; Luisa Mestroni
Journal:  Curr Cardiol Rep       Date:  2019-11-26       Impact factor: 2.931

Review 5.  Dilated Cardiomyopathy: Genetic Determinants and Mechanisms.

Authors:  Elizabeth M McNally; Luisa Mestroni
Journal:  Circ Res       Date:  2017-09-15       Impact factor: 17.367

6.  Dilated cardiomyopathy in a national paediatric population.

Authors:  Muhammad Bassem Jammal Addin; David Young; Sarah McCarrison; Lindsey Hunter
Journal:  Eur J Pediatr       Date:  2019-06-11       Impact factor: 3.183

7.  Endothelial EphB4 maintains vascular integrity and transport function in adult heart.

Authors:  Guillermo Luxán; Jonas Stewen; Mara E Pitulescu; Ralf H Adams; Noelia Díaz; Katsuhiro Kato; Sathish K Maney; Anusha Aravamudhan; Frank Berkenfeld; Nina Nagelmann; Hannes Ca Drexler; Dagmar Zeuschner; Cornelius Faber; Hermann Schillers; Sven Hermann; John Wiseman; Juan M Vaquerizas
Journal:  Elife       Date:  2019-11-29       Impact factor: 8.140

Review 8.  Genetics of Dilated Cardiomyopathy.

Authors:  Yiwen Fu; Howard J Eisen
Journal:  Curr Cardiol Rep       Date:  2018-09-27       Impact factor: 2.931

Review 9.  Genetics of Dilated Cardiomyopathy: Clinical Implications.

Authors:  A Paldino; G De Angelis; M Merlo; M Gigli; M Dal Ferro; G M Severini; L Mestroni; G Sinagra
Journal:  Curr Cardiol Rep       Date:  2018-08-13       Impact factor: 2.931

10.  Altered Enhancer and Promoter Usage Leads to Differential Gene Expression in the Normal and Failed Human Heart.

Authors:  Anthony M Gacita; Lisa Dellefave-Castillo; Patrick G T Page; David Y Barefield; J Andrew Wasserstrom; Megan J Puckelwartz; Marcelo A Nobrega; Elizabeth M McNally
Journal:  Circ Heart Fail       Date:  2020-09-30       Impact factor: 8.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.